Stock GRANULES GRANULES INDIA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

News Granules India Limited

Equities

GRANULES

INE101D01020

Market Closed - Bombay S.E.
Other stock markets
 06:00:50 2024-05-03 am EDT 		5-day change 1st Jan Change
423.4 INR -0.38% Intraday chart for Granules India Limited -0.22% +4.43%
Apr. 30 Granules Pharmaceuticals Arm Gets US FDA's Approval for Generic Drug for Gout Flares MT
Apr. 15 Granules India Gets Zero Observation from US FDA After Inspection of Visakhapatnam, India Unit MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Granules India : ANDA Approval for Colchicine Capsules 0.6 mg
PU
Granules Pharmaceuticals Arm Gets US FDA's Approval for Generic Drug for Gout Flares
MT
Granules India Gets Zero Observation from US FDA After Inspection of Visakhapatnam, India Unit
MT
Granules India Unit Gets VAI Status for Virginia Facility
MT
Granules India Limited Announces Appointment of Directors
CI
Granules India Limited Announces Cessation of Arun Rao Akinepally as Independent Director
CI
Granules India Limited Announces Appointment of Sethu Madhavan Sankaran as Senior Vice President - Api Manufacturing & Operations
CI
Granules India Limited Appoints Atul Dhavle as Chief Human Resources Officer
CI
Granules India Limited Announces That J. Shravan Reddy Shall Cease to Be Senior Vice President & Head- API Manufacturing
CI
Transcript : Granules India Limited, Q3 2024 Earnings Call, Jan 23, 2024
Paracetamol maker Granules India posts marginal rise in Q3 profit
RE
Granules India's Posts Gains in Fiscal Q3 Consolidated Net Profit
MT
Granules India Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
Granules Pharmaceuticals Unit's Virginia Facility Gets Five Observations from US FDA
MT
Granules India Gets US FDA Nod for Pantoprazole Sodium Delayed-Release Tablets
MT
Granules India Limited Receives ANDA Approval for Pantoprazole Sodium Delayed-Release Tablets
CI
Granules India Arm Gets US FDA Nod for Sildenafil for Oral Suspension
MT
Paracetamol maker Granules India's Q2 revenue rises on higher N.America demand
RE
Transcript : Granules India Limited, Q2 2024 Earnings Call, Nov 09, 2023
Granules India Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GRANULES Stock
  4. News Granules India Limited